Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,759.00-1.92%ETH$2,449.71-0.78%GOLD$4,364.00-0.98%OIL$103.08+0.59%
Smart Investors Daily
SX

NASDAQ · SXTC

China SXT Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$2.14

Down-$0.21 (-9.81%)

Updated Sep 11, 2026, 12:41 AM

SID Score

2.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
157.8M
P/E ratio
-1.01
Dividend yield
0.00%
52-week range
$0.05 – $1,046.99
Volume
51.61K
Avg. volume
136.47K

Price performance

SXTC price history

1M range · 19 trading sessions · Daily adjusted prices

SXTC closed at $2.14 after 19 trading sessions, down 35.15% for the selected period.

Last close
$2.14
Period change
-35.15%
Period low
$2.14
Period high
$5.13
Daily close
View OHLC price history
SXTC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 9, 2026$2.30$2.3863$2.14$2.1451.61K
Sep 8, 2026$2.33$2.35$2.21$2.2436.92K
Sep 4, 2026$2.23$2.3642$2.20$2.2350.53K
Sep 3, 2026$2.2409$2.35$2.16$2.2049.73K
Sep 2, 2026$2.50$2.50$2.06$2.22106.51K
Sep 1, 2026$2.55$2.91$2.37$2.46129.89K
Aug 31, 2026$3.03$3.05$2.55$2.56166.75K
Aug 28, 2026$3.33$3.34$3.00$3.00136.76K
Aug 27, 2026$3.62$3.63$3.46$3.46110.96K
Aug 26, 2026$3.59$3.73$3.55$3.5676.86K
Aug 25, 2026$3.50$3.79$3.47$3.58178.88K
Aug 24, 2026$3.97$4.00$3.75$3.80148.45K
Aug 21, 2026$3.83$4.26$3.82$4.103M
Aug 20, 2026$4.29$4.3949$3.60$3.63272.67K
Aug 19, 2026$5.00$5.10$4.30$4.54436.47K
Aug 18, 2026$4.79$5.55$4.20$5.1313.23M
Aug 17, 2026$3.78$4.24$3.60$3.75490.86K
Aug 14, 2026$4.60$4.86$3.68$4.3316.11M
Aug 13, 2026$3.43$3.54$3.10$3.30327.17K

Latest SXTC news

The latest Smart Investors Daily articles mentioning SXTC.

Stock researchCompany · Overview

SXTC research

Overview

Company profile and research snapshot.

Company profile

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 15, 2026

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced as part of its Artificial Intelligence (AI) Insight

Yahoo · Jan 13, 2026

Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)

New York, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $10 million for its client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company” or “China SXT”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By